List view / Grid view
A new race is well underway involving big pharma and…
A new race is well underway involving big pharma and big data companies to see who can most effectively mine the new massive data using artificial intelligence (AI). The aim: reducing costs by using targeted in silico analysis, reducing in vitro and in vivo screening, and reviewing huge quantities of…
Dr Goodwin is the latest top-level scientist to join DTR's…
Dr Goodwin is the latest top-level scientist to join DTR's advisory board
Principal Scientist, Drug Safety and Metabolism at AstraZeneca
11 October 2017 | By
Principal Scientist, Drug Safety and Metabolism at AstraZeneca
Mass spectrometry imaging allows direct measurement of the molecular composition…
Mass spectrometry imaging allows direct measurement of the molecular composition of a sample. It can be used to image the spatial distribution of exogenous drugs and endogenous metabolites simultaneously over the surface of tissue sections or small biopsy, allowing new insights into both compound efficacy and safety during drug discovery.
This In-Depth Focus explores current uses and future development in…
This In-Depth Focus explores current uses and future development in mass spectrometry imaging for bringing new drugs to market...
Included in this issue: The importance of industry partnerships; Calcilytics…
Included in this issue: The importance of industry partnerships; Calcilytics as potential novel therapeutic treatments to halt Alzheimer's disease; Accelerating neuroscience research with flow cytometry...
